PON1 and diabetes mellitus: It should be kept in mind that transcriptional modulation in diabetes in vivo is supposedly much more complex, and exact conditions, such as chronic microinflammation, hyper- or hypo-insulinemia and ROS accumulation, which might affect PON1 expression, have not been successfully reconstructed in vitro.